Latest in AI

A Chinese Domestic Player Finally Cracks the Vicious Cycle Trapping Medical AI

Medical AI in China—and globally—has long been trapped in interlocking chicken-and-egg problems: you need clinical data to build good models, regulatory approval to deploy, and deployment evidence to earn approval. A Chinese domestic player, highlighted by QbitAI, is reported to have navigated this full end-to-end gauntlet. If validated, the breakthrough could offer a replicable commercial template for the broader medical AI sector in China.